Safe Orthopaedics Financials
| ALSAF Stock | EUR 0.07 0 4.99% |
Safe |
Understanding current and past Safe Orthopaedics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Safe Orthopaedics' financial statements are interrelated, with each one affecting the others. For example, an increase in Safe Orthopaedics' assets may result in an increase in income on the income statement.
Safe Orthopaedics Stock Summary
Safe Orthopaedics competes with Spineguard, Spineway, Biophytis, and Acheter Louer. Safe Orthopaedics SA, a medical technology company, develops and markets sterile implants and single-use instruments for the treatment of spinal fracture pathologies in France and internationally. The company was founded in 2010 and is headquartered in ragny-sur-Oise, France. SAFE ORTHOPAEDICS operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 134 people.| Instrument | France Stock View All |
| Exchange | Euronext Paris |
| ISIN | FR001400F1V2 |
| Business Address | Parc des Bellevues, |
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Benchmark | Dow Jones Industrial |
| Website | www.safeorthopaedics.com |
| Phone | 33 1 34 21 50 00 |
| Currency | EUR - Euro |
You should never invest in Safe Orthopaedics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Safe Stock, because this is throwing your money away. Analyzing the key information contained in Safe Orthopaedics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Safe Orthopaedics Key Financial Ratios
Safe Orthopaedics' financial ratios allow both analysts and investors to convert raw data from Safe Orthopaedics' financial statements into concise, actionable information that can be used to evaluate the performance of Safe Orthopaedics over time and compare it to other companies across industries.| Return On Equity | -639.4 | |||
| Return On Asset | -0.28 | |||
| Target Price | 0.32 | |||
| Number Of Employees | 136 | |||
| Beta | 1.78 |
Safe Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Safe Orthopaedics's current stock value. Our valuation model uses many indicators to compare Safe Orthopaedics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Safe Orthopaedics competition to find correlations between indicators driving Safe Orthopaedics's intrinsic value. More Info.Safe Orthopaedics SA is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Safe Orthopaedics' earnings, one of the primary drivers of an investment's value.Safe Orthopaedics Systematic Risk
Safe Orthopaedics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Safe Orthopaedics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Safe Orthopaedics correlated with the market. If Beta is less than 0 Safe Orthopaedics generally moves in the opposite direction as compared to the market. If Safe Orthopaedics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Safe Orthopaedics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Safe Orthopaedics is generally in the same direction as the market. If Beta > 1 Safe Orthopaedics moves generally in the same direction as, but more than the movement of the benchmark.
Safe Orthopaedics December 4, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Safe Orthopaedics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Safe Orthopaedics SA. We use our internally-developed statistical techniques to arrive at the intrinsic value of Safe Orthopaedics SA based on widely used predictive technical indicators. In general, we focus on analyzing Safe Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Safe Orthopaedics's daily price indicators and compare them against related drivers.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 115.56 | |||
| Value At Risk | (17.41) | |||
| Potential Upside | 13.79 |
Additional Tools for Safe Stock Analysis
When running Safe Orthopaedics' price analysis, check to measure Safe Orthopaedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Safe Orthopaedics is operating at the current time. Most of Safe Orthopaedics' value examination focuses on studying past and present price action to predict the probability of Safe Orthopaedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Safe Orthopaedics' price. Additionally, you may evaluate how the addition of Safe Orthopaedics to your portfolios can decrease your overall portfolio volatility.